Amneal Pharmaceuticals, Inc. (2DT.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 09:59AM CEST. Market open.
| Previous close | 5.75 |
| Open | 6.10 |
| Bid | 6.20 x 0 |
| Ask | 6.40 x 0 |
| Day's range | 6.10 - 6.15 |
| 52-week range | 1.60 - 6.15 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 2.079B |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Amneal Reports First Quarter 2024 Financial Results
BRIDGEWATER, N.J., May 03, 2024--AMNEAL REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
- Business Wire
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
BRIDGEWATER, N.J., April 24, 2024--Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
- Business Wire
Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
BRIDGEWATER, N.J., April 16, 2024--Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
© 2024 Yahoo. All rights reserved.